Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel, Cisplatin, 5-FU, and Leucovorin for Carcinoma of the Nasopharnyx
NCT00004164Phase 2Unknown
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Aug 1999
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin, fluorouracil, folinic acid in nasopharyngeal carcinoma (NPC), sponsored by Dana-Farber Cancer Institute. Status: unknown.
02
Drugs
docetaxelcisplatinfluorouracilfolinic acid
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00004164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004164.